Canada Neuraminidase Inhibitors Market (2025-2031) | Outlook, Size & Revenue, Growth, Companies, Segmentation, Trends, Forecast, Competitive Landscape, Analysis, Share, Value, Industry

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Canada Country Macro Economic Indicators

3.2 Canada Neuraminidase Inhibitors Market Revenues & Volume, 2021 & 2031F

3.3 Canada Neuraminidase Inhibitors Market - Industry Life Cycle

3.4 Canada Neuraminidase Inhibitors Market - Porter's Five Forces

3.5 Canada Neuraminidase Inhibitors Market Revenues & Volume Share, By Indication, 2021 & 2031F

3.6 Canada Neuraminidase Inhibitors Market Revenues & Volume Share, By Product, 2021 & 2031F

3.7 Canada Neuraminidase Inhibitors Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.8 Canada Neuraminidase Inhibitors Market Revenues & Volume Share, By End User, 2021 & 2031F

3.9 Canada Neuraminidase Inhibitors Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Growing prevalence of influenza in Canada

4.2.2 Increasing awareness about the benefits of neuraminidase inhibitors for treating influenza

4.2.3 Rising healthcare expenditure and government initiatives to combat infectious diseases

4.3 Market Restraints

4.3.1 High cost of neuraminidase inhibitors leading to limited affordability

4.3.2 Competition from alternative treatments for influenza

4.3.3 Potential side effects and safety concerns associated with neuraminidase inhibitors

6.1 Canada Neuraminidase Inhibitors Market, By Indication

6.1.1 Overview and Analysis

6.1.2 Canada Neuraminidase Inhibitors Market Revenues & Volume, By Indication, 2021- 2031F

6.1.3 Canada Neuraminidase Inhibitors Market Revenues & Volume, By Influenza Virus Type A, 2021- 2031F

6.1.4 Canada Neuraminidase Inhibitors Market Revenues & Volume, By Influenza Virus Type B, 2021- 2031F

6.1.5 Canada Neuraminidase Inhibitors Market Revenues & Volume, By Others, 2021- 2031F

6.2 Canada Neuraminidase Inhibitors Market, By Product

6.2.1 Overview and Analysis

6.2.2 Canada Neuraminidase Inhibitors Market Revenues & Volume, By Zanamivir, 2021- 2031F

6.2.3 Canada Neuraminidase Inhibitors Market Revenues & Volume, By Oseltamivir, 2021- 2031F

6.2.4 Canada Neuraminidase Inhibitors Market Revenues & Volume, By Peramivir, 2021- 2031F

6.2.5 Canada Neuraminidase Inhibitors Market Revenues & Volume, By Laninamivir, 2021- 2031F

6.2.6 Canada Neuraminidase Inhibitors Market Revenues & Volume, By Other, 2021- 2031F

6.3 Canada Neuraminidase Inhibitors Market, By Route of Administration

6.3.1 Overview and Analysis

6.3.2 Canada Neuraminidase Inhibitors Market Revenues & Volume, By Oral, 2021- 2031F

6.3.3 Canada Neuraminidase Inhibitors Market Revenues & Volume, By Inhalation, 2021- 2031F

6.3.4 Canada Neuraminidase Inhibitors Market Revenues & Volume, By Parenteral, 2021- 2031F

6.3.5 Canada Neuraminidase Inhibitors Market Revenues & Volume, By Others, 2021- 2031F

6.4 Canada Neuraminidase Inhibitors Market, By End User

6.4.1 Overview and Analysis

6.4.2 Canada Neuraminidase Inhibitors Market Revenues & Volume, By Hospitals, 2021- 2031F

6.4.3 Canada Neuraminidase Inhibitors Market Revenues & Volume, By Homecare, 2021- 2031F

6.4.4 Canada Neuraminidase Inhibitors Market Revenues & Volume, By Specialty Clinics, 2021- 2031F

6.4.5 Canada Neuraminidase Inhibitors Market Revenues & Volume, By Others, 2021- 2031F

6.5 Canada Neuraminidase Inhibitors Market, By Distribution Channel

6.5.1 Overview and Analysis

6.5.2 Canada Neuraminidase Inhibitors Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F

6.5.3 Canada Neuraminidase Inhibitors Market Revenues & Volume, By Online Pharmacy, 2021- 2031F

6.5.4 Canada Neuraminidase Inhibitors Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F

7.1 Canada Neuraminidase Inhibitors Market Export to Major Countries

7.2 Canada Neuraminidase Inhibitors Market Imports from Major Countries

8.1 Patient adherence rate to neuraminidase inhibitor treatment

8.2 Number of prescriptions for neuraminidase inhibitors

8.3 Rate of new product development and approvals in the neuraminidase inhibitors market

9.1 Canada Neuraminidase Inhibitors Market Opportunity Assessment, By Indication, 2021 & 2031F

9.2 Canada Neuraminidase Inhibitors Market Opportunity Assessment, By Product, 2021 & 2031F

9.3 Canada Neuraminidase Inhibitors Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.4 Canada Neuraminidase Inhibitors Market Opportunity Assessment, By End User, 2021 & 2031F

9.5 Canada Neuraminidase Inhibitors Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10.1 Canada Neuraminidase Inhibitors Market Revenue Share, By Companies, 2024

10.2 Canada Neuraminidase Inhibitors Market Competitive Benchmarking, By Operating and Technical Parameters